Fate Therapeutics (FATE) Stock News
$FATE · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Fate Therapeutics (FATE) in the past 30 days. BORSA’s news read on FATE is balanced at 50/100, based on 1 company event over the past 7 days. Fate Therapeutics’ next earnings report is scheduled for Thursday, Nov 12.
The wire on $FATE
newest first · updated · direct subject stories onlyFate Therapeutics grants inducement stock options and RSUs to new hires
Fate Therapeutics awarded 300,000 stock options and 87,000 RSUs to three newly hired non-executive employees as inducement awards. The grants vest over four years and are standard practice for attracting talent.
neutral 50 · impact 10The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
BORSAPLUSNews on Price · Earnings read · Flow and ownership · Options context
Create a free account · no card Fate Therapeutics (FATE) stock: common questions
What is the latest Fate Therapeutics stock news?
The highest-impact FATE story BORSA published in the past 30 days:
· Fate Therapeutics grants inducement stock options and RSUs to new hires